EcoDrugPlus

Retinoic Acid Receptor Alpha

Ensembl ID : ENSPPRG00000012680
Gene Symbol: RARA
4 Cross references
331 Possible Orthologues:

Retinoic Acid Receptor Beta

Ensembl ID : ENSPPRG00000002709
Gene Symbol: RARB
4 Cross references
450 Possible Orthologues:

Retinoic Acid Receptor Gamma

Ensembl ID : ENSPPRG00000016824
Gene Symbol: RARG
3 Cross references
447 Possible Orthologues:

Retinoid X Receptor Alpha

Ensembl ID : ENSPPRG00000001805
Gene Symbol: RXRA
4 Cross references
244 Possible Orthologues:

Retinoid X Receptor Beta

Ensembl ID : ENSPPRG00000010222
Gene Symbol: RXRB
3 Cross references
234 Possible Orthologues:

Retinoid X Receptor Gamma

Ensembl ID : ENSPPRG00000007988
Gene Symbol: RXRG
4 Cross references
274 Possible Orthologues:

Ribosomal Protein L10a

Ensembl ID : ENSPPRG00000013138
Gene Symbol: RPL10A
4 Cross references
161 Possible Orthologues:

Ribosomal Protein L11

Ensembl ID : ENSPPRG00000007647
Gene Symbol: RPL11
4 Cross references
158 Possible Orthologues:

Ribosomal Protein L13

Ensembl ID : ENSPPRG00000003949
Gene Symbol: RPL13
4 Cross references
266 Possible Orthologues:

Ribosomal Protein L18

Ensembl ID : ENSPPRG00000022938
Gene Symbol: RPL18
3 Cross references
131 Possible Orthologues:

Ribosomal Protein L19

Ensembl ID : ENSPPRG00000023068
Gene Symbol: RPL19
4 Cross references
205 Possible Orthologues:

Ribosomal Protein L22

Ensembl ID : ENSPPRG00000006034
Gene Symbol: RPL22
4 Cross references
55 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).